PiaMaaritHerbolsheimerMD
Oncology • Washington, DCAssistant Professor, Medicine, Georgetown Univ Sch of Med
Are you Dr. Herbolsheimer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
110 Irving St Nw
Washington, DC 20010Phone+1 202-877-7000- Is this information wrong?
Summary
- Dr. Pia Herbolsheimer, MD is an oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia and Maryland. She is affiliated with MedStar Washington Hospital Center and is an Assistant Professor at Georgetown Univ Sch of Med.
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2007 - 2010- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2004 - 2007
Certifications & Licensure
DC State Medical License 2007 - 2016
MD State Medical License 2011 - 2016
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013-2014
Clinical Trials
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 5 citationsOlaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study.Matthew G Krebs, Jean-Pierre Delord, Thomas R Jeffry Evans, Maja De Jonge, Sang-We Kim, Marie Meurer, Sophie Postel-Vinay, Jong-Seok Lee, Helen K Angell, Vidalba Roche...> ;Lung Cancer. 2023 Jun 1
- 17 citationsLong-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compr...Katia E. Khoury, Filipa Lynce, Ana Barac, Xue Geng, Chau T. Dang, Anthony F. Yu, Karen L. Smith, Christopher Gallagher, Paula R. Pohlmann, Raquel Nunes, P. Herbolsheim...> ;Breast Cancer Research and Treatment. 2021 Jan 5
- 214 citationsOlaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.Susan M. Domchek, Sophie Postel-Vinay, Seock-Ah Im, Yeon Hee Park, Jean Pierre Delord, Antoine Italiano, Jérôme Alexandre, Benoit You, Sara Bastian, Matthew G Krebs, D...> ;The Lancet. Oncology. 2020 Sep 1
- Join now to see all
Hospital Affiliations
MedStar Washington Hospital CenterWashington, District of Columbia
